Helicobacter pylori infection and current clinical areas of contention.
about
Helicobacter pylori in humans: Where are we now?Exploring alternative treatments for Helicobacter pylori infectionEpidemiology of Helicobacter pylori infection and public health implicationsPolymorphism in the Helicobacter pylori CagA and VacA toxins and diseaseA prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study.Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.Helicobacter pylori eradication for preventing gastric cancer14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.Helicobacter pylori: Eradication or Preservation.Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle massCurrent evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer.Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.Guidelines for treatment of Helicobacter pylori in the East and West.Iron trafficking system in Helicobacter pylori.Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?p27(kip1) upregulated by hnRNPC1/2 antagonizes CagA (a virulence factor of Helicobacter pylori)-mediated pathogenesis.Octyl gallate, a food additive with potential beneficial properties to treat Helicobacter pylori infection.Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication.General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
P2860
Q26825856-54225243-1A5A-4F24-A605-B22752398CBDQ26828017-748C663C-BB6A-4B0D-80A6-69B5DBC9FADDQ26865284-429F37F3-E32C-43B1-89EC-22146DCBF2A7Q27005785-5795BE7E-5CC6-4BDE-8497-702C31E36022Q30528584-5C45DFFE-FAF9-46BF-87D1-0C3A08E0EF3EQ33594856-1319B954-2A2B-4195-A108-C364A06437BCQ33626785-11C7F779-4652-47FD-AD76-472408670983Q35855301-496CB7B9-0BAC-483B-8426-48B7AE415D24Q35867151-25B6F225-5F8C-4393-BABD-83C3373B330BQ36214570-73090F80-6237-4E49-BCB8-00E2912CC769Q36253202-AEAFA559-3025-4B75-ACF3-955760C71096Q37138735-6B693C71-5E85-4918-909E-E363005AE588Q37247773-29F09518-20EE-4A65-BE7E-404797A4B3CAQ37912220-C685070D-6738-4744-9C01-BB9DB537C41BQ37962800-53592E14-D976-4B37-8EF7-EB18EBA01FC1Q38355546-35664DEE-BDE0-4D02-A8BD-CE1D34F2D62AQ39382674-3CD6EA8F-58A8-4F45-B9EE-1A22F6DD1F5AQ40162161-6A50C14D-9C30-4534-B229-9A9733D1FC4EQ41008910-3285EB72-BFCD-424F-986F-5C8679226CC0Q41143975-61274ECD-D682-4C0A-9C87-4A2F8F2D29A5Q41566014-CA83B707-2CED-4FFD-83C4-9E6CC4913CE2
P2860
Helicobacter pylori infection and current clinical areas of contention.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Helicobacter pylori infection and current clinical areas of contention.
@ast
Helicobacter pylori infection and current clinical areas of contention.
@en
type
label
Helicobacter pylori infection and current clinical areas of contention.
@ast
Helicobacter pylori infection and current clinical areas of contention.
@en
prefLabel
Helicobacter pylori infection and current clinical areas of contention.
@ast
Helicobacter pylori infection and current clinical areas of contention.
@en
P1476
Helicobacter pylori infection and current clinical areas of contention.
@en
P2093
Michael Selgrad
P304
P356
10.1097/MOG.0B013E32833EFEDE
P577
2010-11-01T00:00:00Z